메뉴 건너뛰기




Volumn 49, Issue 30, 2000, Pages 685-687

Missed opportunities for prevention of tuberculosis among persons with HIV infection - Selected locations, United States, 1996-1997
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

EID: 0034604344     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (19)

References (10)
  • 1
    • 0002013312 scopus 로고
    • Controlled chemoprophylaxis trials in tuberculosis: A general review
    • Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis: a general review. Advances in Tuberculosis Research 1970;17:28-106.
    • (1970) Advances in Tuberculosis Research , vol.17 , pp. 28-106
    • Ferebee, S.H.1
  • 2
    • 0031035020 scopus 로고    scopus 로고
    • Incidence of tuberculosis in the United States among HIV-infected persons
    • Markowitz N, Hansen NI, Hopewell PC, et al. Incidence of tuberculosis in the United States among HIV-infected persons. Ann Intern Med 1997;126:123-32.
    • (1997) Ann Intern Med , vol.126 , pp. 123-132
    • Markowitz, N.1    Hansen, N.I.2    Hopewell, P.C.3
  • 3
    • 0028226440 scopus 로고
    • Treatment of tuberculosis and tuberculosis infection in adults and children
    • American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994;149:1370.
    • (1994) Am J Respir Crit Care Med , vol.149 , pp. 1370
  • 4
    • 0003981303 scopus 로고
    • Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, CDC
    • CDC. Core curriculum on tuberculosis: what the clinician should know. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, CDC, 1994:33-4.
    • (1994) Core Curriculum on Tuberculosis: What the Clinician Should Know , pp. 33-34
  • 5
    • 0032582422 scopus 로고    scopus 로고
    • Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations
    • CDC. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR 1998;47(no. RR-20):37-41.
    • (1998) MMWR , vol.47 , Issue.RR-20 , pp. 37-41
  • 7
    • 0031587874 scopus 로고    scopus 로고
    • 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus
    • CDC. 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. MMWR 1997;46(no. RR-12):10.
    • (1997) MMWR , vol.46 , Issue.RR-12 , pp. 10
  • 8
    • 0026452573 scopus 로고
    • Control of tuberculosis in the United States
    • American Thoracic Society. Control of tuberculosis in the United States. American Review of Respiratory Disease 1992;6:1623-33.
    • (1992) American Review of Respiratory Disease , vol.6 , pp. 1623-1633
  • 9
    • 0039466022 scopus 로고    scopus 로고
    • Anergy skin testing and preventive therapy for HIV-infected persons: Revised recommendations
    • CDC. Anergy skin testing and preventive therapy for HIV-infected persons: revised recommendations. MMWR 1997;46(no. RR-15):7.
    • (1997) MMWR , vol.46 , Issue.RR-15 , pp. 7
  • 10
    • 0034091974 scopus 로고    scopus 로고
    • Targeted tuberculin testing and treatment of latent tuberculosis infection
    • American Thoracic Society and CDC. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161(part 2):S221-S247.
    • (2000) Am J Respir Crit Care Med , vol.161 , Issue.2 PART


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.